Results 71 to 80 of about 339 (90)
Some of the next articles are maybe not open access.
Antieosinophilic Activity of Simendans
The Journal of Pharmacology and Experimental Therapeutics, 2007Simendans are novel agents used in the treatment of decompensated heart failure. They sensitize troponin C to calcium and open ATP-sensitive potassium channels and have been shown to reduce cardiac myocyte apoptosis. The aim of the present study was to evaluate whether simendans reduce pulmonary eosinophilia and regulate eosinophil apoptosis ...
Hannu, Kankaanranta +6 more
openaire +2 more sources
Enatiomeric analysis of simendan by CE with β‐CD as chiral selector compared with CMPA‐HPLC
Biomedical Chromatography, 2004AbstractThe chiral separation of simendan enantiomers using capillary electrophoresis was studied with β‐cyclodextrin (β‐CD) as chiral selector. The influences of the concentration and pH of borate buffer solution, β‐CD concentration and methanol content in the background electrolyte were investigated.
Famei, Li +4 more
openaire +2 more sources
The effects of a new calcium sensitizer, Simendan, on intra-cellular protein phosphorylation
Journal of Molecular and Cellular Cardiology, 1992István Édes +2 more
openaire +1 more source
Studies on calcium-dependent binding of simendan to troponin complex and troponin C
Journal of Molecular and Cellular Cardiology, 1992Martti Ovaska +5 more
openaire +1 more source
Simendan and aortic valve replacement in treatment brucelosis congestive heart failure
2013Krdzalic, Alisa +4 more
openaire +1 more source